Mustang CAR-T brain tumor trial gets funds to expand – FierceBiotech
FierceBiotech |
Mustang CAR–T brain tumor trial gets funds to expand
FierceBiotech The other three arms are assessing delivering the CAR–T cells to either the tumor, the cerebrospinal fluid or a cavity left by the removal of the cancer, also known respectively as intratumoral, intraventricular and intracavitary administration. The … Mustang Bio (MBIO) Announces $12.8M Grant to Fund Phase 1 Trial of CAR T Therapy MB-101 in Malignant Glioma |
